Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSelling tirzepatide without a valid prescription is illegal in the UK. Tirzepatide is a Prescription-Only Medicine under the Human Medicines Regulations 2012, which means it can only be supplied by a registered pharmacy acting on a prescription issued by a qualified prescriber. No legitimate seller can hand it over without that process. If you've stumbled across listings that appear to skip those steps, you're right to be suspicious — and this page explains exactly what the law covers, what enforcement looks like, and how to tell a genuine source from one that isn't. These are prescription medicines; a clinician decides who they are suitable for.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is the misconception worth clearing up first. The existence of a listing (on a website, a social-media account, a messaging app) tells you nothing about whether the sale is lawful. Tirzepatide is classified as a Prescription-Only Medicine (POM) in the UK under the Human Medicines Regulations 2012. That classification carries a specific legal consequence: the medicine can only be sold or supplied to a patient by a pharmacy that holds a valid GPhC registration, and only when a qualified prescriber has issued a prescription for that individual patient.
Selling tirzepatide through any other route (a private individual, an unregistered website, a social-media seller) is a criminal offence. The law does not have a grey area here. The volume of listings you might find does not dilute the illegality; it just reflects the scale of the enforcement problem the MHRA is working through. If you have found what looks like a cheap or easy source, the question to ask is not whether it is technically allowed, but why it appears to be bypassing the steps the law requires.
The NHS medicines page for tirzepatide sets out clearly that this is a prescription medicine, and the MHRA has published multiple public warnings about illegal supply. If you want to understand exactly whether tirzepatide is legal to buy in the UK and under what conditions, that framing matters before anything else.
If selling tirzepatide without proper authorisation were a minor technical breach, you might expect occasional small fines. The reality has been rather different. By late 2025 MHRA enforcement operations had seized roughly 20 million doses of illegally traded weight-loss medicines with an estimated street value around £45m. In October 2025, investigators raided a site in Northampton that had been manufacturing counterfeit tirzepatide pens inside the UK.
Those pens were not subpotent or poorly stored versions of the real thing. Counterfeit weight-loss pens seized during earlier operations contained insulin rather than the stated active ingredient, and some recipients needed hospital treatment. That is the practical consequence of supply outside the licensed chain: there is no quality control, no cold-chain assurance, and no clinical oversight of who receives what dose.
Our page on what makes tirzepatide sales illegal goes into further detail on the specific offences involved, and the MHRA's position is straightforward: report any suspected illegal seller via the Yellow Card scheme, which handles both safety reports and intelligence about suspect products or suppliers. The scheme is free and can be used anonymously.
If you want to understand more about how the legal supply chain is structured for Mounjaro specifically, our page on the rules around selling Mounjaro covers the pharmacy and prescriber obligations in more detail.
A genuine, lawful supply of tirzepatide involves three things working together: a prescriber who is qualified and registered, a pharmacy that holds a GPhC premises registration, and a prescription written specifically for you after a clinical assessment of your circumstances.
You can check any online pharmacy on the GPhC's public register at pharmacyregulation.org/registers in under a minute. If a pharmacy does not appear there, do not use it. Equally, if a service offers to supply tirzepatide without asking you a single clinical question, or offers it at a price dramatically below the market range, those are the signals that something is wrong.
For context on what private supply legitimately costs, our Mounjaro pricing page sets out the market picture honestly, including what a transparent single price should cover. The short version: a lawful prescription service includes consultation, clinical review, and the medicine itself, with no hidden extras.
At nume, every consultation is read and decided upon by a GPhC-registered Independent Prescriber, a named clinician, not an automated process. Our pharmacy's GPhC registration number is 9012878, verifiable directly at the GPhC register. We understand that working out who to trust online is genuinely stressful, and that scepticism is the right starting position. That is precisely why those verification steps exist.
The law creates a clear path, not a barrier. If tirzepatide is clinically appropriate for you, a registered pharmacy can supply it lawfully, it just requires a proper assessment first. You do not need a GP referral or a long NHS wait to access private treatment; you do need a prescriber to review your health information and confirm suitability.
For a broader picture of what the tirzepatide assessment involves, our page on what tirzepatide is and how it works covers the clinical background in plain terms. If you are also trying to understand how tirzepatide relates to the Mounjaro brand name, the page on whether tirzepatide and Mounjaro are the same thing clarifies that directly.
The NICE guidance on tirzepatide (TA1026) and the broader weight-loss treatment options available in the UK are worth reading alongside the legal picture, because eligibility and legality are two separate questions, and both matter.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.